The Patent Finder

Cymabay Therapeutics, Inc.

Also on record
Records under this name other than the patents Cymabay Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 28 patents it holds.

Back to Cymabay Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,098,843Compositions of 5-Ethyl-2-{4-[4-(4-Tetrazol-1-YL-PHENOXYMETHYL)-THIAZOL-2-YL]-PIPERIDIN-1-YL}-PYRIMIDINE
Lapsed on the fee record
Ended Oct 16, 2026 · Low confidence
Lapsed on the fee recordEnded Oct 16, 2026Low confidence
US 8,815,886Substituted TETRAZOL-1-YL-PHENOXYMETHYL-THIAZOL-2-YL-PIPERIDINYL-PYRIMIDINE Salts
Lapsed on the fee record
Ended Aug 26, 2026 · High confidence
Lapsed on the fee recordEnded Aug 26, 2026High confidence
US 9,925,189Heterocyclic Receptor Agonists for the Treatment of Diabetes and Metabolic Disorders
Lapsed on the fee record
Ended Mar 27, 2026 · Medium confidence
Lapsed on the fee recordEnded Mar 27, 2026Medium confidence
US 8,541,614Process for the Preparation of (-)-(4-Chloro-PHENYL)-(3-Trifluoromethyl-PHENOXY)-ACETIC Acid 2-Acetylamino-ETHYL Ester
now held by Diatex, Inc.
Lapsed on the fee record
Ended Sep 24, 2025 · High confidence
Lapsed on the fee recordEnded Sep 24, 2025High confidence
US 9,737,537Heterocyclic Receptor Agonists for the Treatment of Diabetes and Metabolic Disorders
Lapsed on the fee record
Ended Aug 22, 2025 · Medium confidence
Lapsed on the fee recordEnded Aug 22, 2025Medium confidence
US 7,323,480Substituted Triazoles as Modulators of Ppar and Methods of Their Preparation
Term ended
Term ended May 24, 2025 · High confidence
Term endedTerm ended May 24, 2025High confidence
US 8,410,127Substituted TETRAZOL-1-YL-PHENOXYMETHYL-THIAZOL-2-YL-PIPERIDINYL-PYRIMIDINE Salts
Lapsed on the fee record
Ended Apr 2, 2025 · High confidence
Lapsed on the fee recordEnded Apr 2, 2025High confidence
US 8,288,384Heterocyclic Receptor Agonists for the Treatment of Diabetes and Metabolic Disorders
Lapsed on the fee record
Ended Oct 16, 2024 · Medium confidence
Lapsed on the fee recordEnded Oct 16, 2024Medium confidence
US 8,227,4952,4-Disubsituted Thiazoles and Pharmaceutical Compositions Thereof
Lapsed on the fee record
Ended Jul 24, 2024 · Medium confidence
Lapsed on the fee recordEnded Jul 24, 2024Medium confidence
US 7,199,259Resolution of Alpha-(PHENOXY)phenylacetic Acid Derivatives
now held by Diatex, Inc.
Term ended
Term ended Apr 17, 2024 · High confidence
Term endedTerm ended Apr 17, 2024High confidence
10 of 83 records shown.
Pro members see all 83.
Pro members: see all 83 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited